ORXOF(ORXOF)
ORXOF
No analyst ratings available
No analyst price targets available for ORXOF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $26M | $27M | $31M |
| Low | $26M | $27M | $31M |
| High | $26M | $27M | $31M |
| EBITDA Avg | $-7M | $-7M | $-8M |
| Low | $-7M | $-7M | $-8M |
| High | $-7M | $-7M | $-8M |
| EBIT Avg | $-10M | $-11M | $-12M |
| Low | $-10M | $-11M | $-12M |
| High | $-10M | $-11M | $-12M |
| Net Income Avg | $-309M | $-247M | $-265M |
| Low | $-309M | $-247M | $-265M |
| High | $-309M | $-247M | $-265M |
| EPS Avg | $-8.94 | $-7.13 | $-7.66 |
| Low | $-8.94 | $-7.13 | $-7.66 |
| High | $-8.94 | $-7.13 | $-7.66 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 |
|---|---|---|
| Revenue Avg | $4M | $6M |
| Low | $4M | $6M |
| High | $4M | $6M |
| EBITDA Avg | $-1M | $-2M |
| Low | $-1M | $-2M |
| High | $-1M | $-2M |
| EBIT Avg | $-2M | $-2M |
| Low | $-2M | $-2M |
| High | $-2M | $-2M |
| Net Income Avg | $-55M | $-78M |
| Low | $-55M | $-78M |
| High | $-55M | $-78M |
| EPS Avg | $-1.39 | $-1.98 |
| Low | $-1.39 | $-1.98 |
| High | $-1.39 | $-1.98 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 |